These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10761715)

  • 21. Acute effects of tumor necrosis factor alpha or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors.
    Kluge M; Elger B; Engel T; Schaefer C; Seega J; Vaupel P
    Cancer Res; 1992 Apr; 52(8):2167-73. PubMed ID: 1559220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on pharmacokinetics of a new biliary excreted oral angiotensin converting enzyme inhibitor, temocapril (CS-622) in humans.
    Suzuki H; Kawaratani T; Shioya H; Uji Y; Saruta T
    Biopharm Drug Dispos; 1993 Jan; 14(1):41-50. PubMed ID: 8427943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.
    Massien C; Azizi M; Guyene TT; Vesterqvist O; Mangold B; Ménard J
    Clin Pharmacol Ther; 1999 Apr; 65(4):448-59. PubMed ID: 10223783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus.
    Kawata T; Daimon M; Hasegawa R; Teramoto K; Toyoda T; Sekine T; Yamamoto K; Uchida D; Himi T; Yoshida K; Komuro I
    Int J Cardiol; 2009 Feb; 132(2):286-8. PubMed ID: 18083252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis.
    Hori K; Saito S
    Br J Cancer; 2003 Oct; 89(7):1334-44. PubMed ID: 14520469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of angiotensin II induced hypertension on tumor blood flow and interstitial fluid pressure.
    Zlotecki RA; Boucher Y; Lee I; Baxter LT; Jain RK
    Cancer Res; 1993 Jun; 53(11):2466-8. PubMed ID: 8495405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
    Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
    J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.
    Suzuki M; Hori K; Abe I; Saito S; Sato H
    J Natl Cancer Inst; 1981 Sep; 67(3):663-9. PubMed ID: 6944536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal angiotensin converting enzyme (ACE) expression in diabetic rats: the effect of ACE inhibitors].
    Yoshikawa H
    Nihon Jinzo Gakkai Shi; 1999 Aug; 41(5):486-92. PubMed ID: 10502942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of temocapril, an angiotensin-converting enzyme inhibitor with preferential biliary excretion, on experimental diabetic nephropathy].
    Yanagisawa Y
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1095-102. PubMed ID: 7815741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of temocapril hydrochloride, a novel angiotensin converting enzyme inhibitor, in renal insufficiency.
    Nakashima M; Yamamoto J; Shibata M; Uematsu T; Shinjo H; Akahori T; Shioya H; Sugiyama K; Kawahara Y
    Eur J Clin Pharmacol; 1992; 43(6):657-9. PubMed ID: 1493850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the hypertensive agent angiotensin II for modifying oxygen delivery to tumours.
    Tozer GM; Shaffi KM; Hirst DG
    Adv Exp Med Biol; 1994; 345():423-9. PubMed ID: 8079738
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of temocapril and temocaprilat after 14 once daily oral doses of temocapril in hypertensive patients with varying degrees of renal impairment.
    Püchler K; Eckl KM; Fritsche L; Renneisen K; Neumayer HH; Sierakowski B; Lavrijssen AT; Thomsen T; Roots I
    Br J Clin Pharmacol; 1997 Dec; 44(6):531-6. PubMed ID: 9431827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment.
    Sierakowski B; Püchler K; Witte PU; Renneisen K; Roots I
    Eur J Clin Pharmacol; 1997; 53(3-4):215-20. PubMed ID: 9476034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase-2 inhibition by temocapril and its important role in peritoneal transport.
    Yamamoto D; Takai S; Akimoto T; Hirahara I; Ito C; Muto S; Kusano E
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):864-8. PubMed ID: 23013132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of temocapril, an ACE inhibitor with preferential biliary excretion, in patients with impaired liver function.
    Furuta S; Kiyosawa K; Higuchi M; Kasahara H; Saito H; Shioya H; Oguchi H
    Eur J Clin Pharmacol; 1993; 44(4):383-5. PubMed ID: 8513851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats.
    Hobara N; Gessei-Tsutsumi N; Goda M; Takayama F; Akiyama S; Kurosaki Y; Kawasaki H
    Hypertens Res; 2005 May; 28(5):465-74. PubMed ID: 16156511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of temocapril and enalapril in patients with various degrees of renal insufficiency.
    Oguchi H; Miyasaka M; Koiwai T; Tokunaga S; Hora K; Sato K; Yoshie T; Shioya H; Furuta S
    Clin Pharmacokinet; 1993 May; 24(5):421-7. PubMed ID: 8504625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Selective enhancement of tumor blood flow and drug delivery to brain tumors in experimental rat gliomas under angiotensin II-induced hypertension].
    Ogasawara H; Kiya K; Kurisu K; Hotta T; Mikami T; Sugiyama K; Uozumi T
    No To Shinkei; 1991 Jul; 43(7):657-62. PubMed ID: 1910950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of interstitial pneumonia induced by an ACE inhibitor (temocapril hydrochloride)].
    Kitasato Y; Ikedo Y; Yamada K; Mizoguchi Y; Hoshino T; Aizawa H
    Nihon Kokyuki Gakkai Zasshi; 2003 Sep; 41(9):660-5. PubMed ID: 14531303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.